» Articles » PMID: 27751556

The Epidemiology of Parkinson's Disease: Risk Factors and Prevention

Overview
Journal Lancet Neurol
Specialty Neurology
Date 2016 Oct 19
PMID 27751556
Citations 740
Authors
Affiliations
Soon will be listed here.
Abstract

Since 2006, several longitudinal studies have assessed environmental or behavioural factors that seem to modify the risk of developing Parkinson's disease. Increased risk of Parkinson's disease has been associated with exposure to pesticides, consumption of dairy products, history of melanoma, and traumatic brain injury, whereas a reduced risk has been reported in association with smoking, caffeine consumption, higher serum urate concentrations, physical activity, and use of ibuprofen and other common medications. Randomised trials are investigating the possibility that some of the negative risk factors might be neuroprotective and thus beneficial in individuals with early Parkinson's disease, particularly with respect to smoking (nicotine), caffeine, and urate. In the future, it might be possible to identify Parkinson's disease in its prodromal phase and to promote neuroprotective interventions before the onset of motor symptoms. At this time, however, the only intervention that seems justifiable for the primary prevention of Parkinson's disease is the promotion of physical activity, which is likely to be beneficial for the prevention of several chronic diseases.

Citing Articles

Effects of different exercises on improving gait performance in patients with Parkinson's disease: a systematic review and network meta-analysis.

Li Y, Huang J, Wang J, Cheng Y Front Aging Neurosci. 2025; 17:1496112.

PMID: 40078641 PMC: 11897016. DOI: 10.3389/fnagi.2025.1496112.


The Correlation Between RIN3 Gene Methylation and Cognitive Impairment in Parkinson's Disease.

Yu X, Zhu K, Wang T, Li H, Zhang X, Zhong X Neuropsychiatr Dis Treat. 2025; 21:511-524.

PMID: 40078451 PMC: 11900794. DOI: 10.2147/NDT.S509510.


Global, regional, and national burden of tobacco-related neurological disorders from 1990 to 2021: Trends and future projections.

Zhang C, An Z, Jiang J, Ge J, Huang W, Pei J Tob Induc Dis. 2025; 23.

PMID: 40078231 PMC: 11897908. DOI: 10.18332/tid/201966.


Projections for prevalence of Parkinson's disease and its driving factors in 195 countries and territories to 2050: modelling study of Global Burden of Disease Study 2021.

Su D, Cui Y, He C, Yin P, Bai R, Zhu J BMJ. 2025; 388:e080952.

PMID: 40044233 PMC: 11881235. DOI: 10.1136/bmj-2024-080952.


Nonmotor Symptom Changes and Their Association With Falls Among Parkinson's Disease Patients Undergoing Deep Brain Stimulation: A 1-Year Cohort Study.

Gao Y, You H, Wang J, Yao M, Li D, Sun B CNS Neurosci Ther. 2025; 31(3):e70310.

PMID: 40022502 PMC: 11871399. DOI: 10.1111/cns.70310.